glucagon has been researched along with 8-methoxymethyl-3-isobutyl-1-methylxanthine in 1 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Trials (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Recent Studies (post-2010) (8-methoxymethyl-3-isobutyl-1-methylxanthine) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 33 | 0 | 13 |
Protein | Taxonomy | glucagon (IC50) | 8-methoxymethyl-3-isobutyl-1-methylxanthine (IC50) |
---|---|---|---|
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | 10 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Bos taurus (cattle) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernández, J; Juan-Fita, MJ; Vargas, ML | 1 |
1 other study(ies) available for glucagon and 8-methoxymethyl-3-isobutyl-1-methylxanthine
Article | Year |
---|---|
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines | 2005 |